EP3217983
ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.11.2015EP published:
1.5.2024EP application number:
15859462.2
EPO information:
European Patent Register
Max expiry date:
11.11.2035
Title in English:
ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENTLanguage of the patent:
English
Timeline
Today
12.11.2015EP application
1.5.2024EP Publication
Owner
Name:
Memorial Sloan Kettering Cancer CenterAddress:
1275 York Avenue, New York, NY 10021, US
Inventor
Name:
KOLESNICK, RichardAddress:
New York, NY 10021, US
Name:
HAIMOVITZ-FRIEDMAN, AdrianaAddress:
New York, NY 10021, US
Name:
SALA, EvisAddress:
New York, NY 10021, US
Name:
FUKS, ZviAddress:
New York, NY 10021, US
Priority
Number:
201462078280 PDate:
11.11.2014Country:
US
Classification
Categories:
A61K 31/517, A61K 31/416, A61K 31/404, A61K 31/136, A61K 31/66, A61K 31/198, A61P 35/00